BR112015017397A2 - compostos pirimidona bicíclica como inibidores de lp-pla2 - Google Patents
compostos pirimidona bicíclica como inibidores de lp-pla2Info
- Publication number
- BR112015017397A2 BR112015017397A2 BR112015017397A BR112015017397A BR112015017397A2 BR 112015017397 A2 BR112015017397 A2 BR 112015017397A2 BR 112015017397 A BR112015017397 A BR 112015017397A BR 112015017397 A BR112015017397 A BR 112015017397A BR 112015017397 A2 BR112015017397 A2 BR 112015017397A2
- Authority
- BR
- Brazil
- Prior art keywords
- pla2 inhibitors
- pyrimidone compounds
- compounds
- pla2
- bicyclic pyrimidone
- Prior art date
Links
- -1 bicyclic pyrimidone compounds Chemical class 0.000 title abstract 2
- 239000003358 phospholipase A2 inhibitor Substances 0.000 title abstract 2
- JQHCTHXYINERDF-UHFFFAOYSA-N 1,2-dihydropyrimido[1,2-c]pyrimidin-6-one Chemical class N1CC=CN2C(=O)N=CC=C21 JQHCTHXYINERDF-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013070977 | 2013-01-25 | ||
| PCT/CN2014/071206 WO2014114249A1 (en) | 2013-01-25 | 2014-01-23 | Bicyclic pyrimidone compounds as inhibitors of lp-pla2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015017397A2 true BR112015017397A2 (pt) | 2017-07-11 |
Family
ID=51226939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015017397A BR112015017397A2 (pt) | 2013-01-25 | 2014-01-23 | compostos pirimidona bicíclica como inibidores de lp-pla2 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150344485A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2948456A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2016505053A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20150108896A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014210260B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015017397A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2899143A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2015135824A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014114249A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015292049B2 (en) | 2014-07-22 | 2017-06-15 | Glaxosmithkline Intellectual Property Development Limited | Compounds |
| CN105777653A (zh) * | 2014-12-26 | 2016-07-20 | 中国科学院上海药物研究所 | 用作Lp-PLA2抑制剂的嘧啶酮类化合物及其药物组合物 |
| CN106188063A (zh) * | 2015-05-08 | 2016-12-07 | 中国科学院上海药物研究所 | 用作Lp-PLA2抑制剂的双环类化合物、其制备方法及医药用途 |
| CN105001098B (zh) * | 2015-07-26 | 2016-09-14 | 嵊州市油脂化工有限公司 | 一种3(r)/(s)-氨基-1-丁醇的制备方法 |
| CA3102631C (en) | 2018-06-08 | 2023-12-19 | Attabotics Inc. | Storage and retrieval systems sharing a common robotic fleet between a storage grid and external workstations |
| CN110683960A (zh) * | 2019-08-22 | 2020-01-14 | 台州达辰药业有限公司 | 一种（r）-3-氨基丁醇的合成方法 |
| CN112574221B (zh) * | 2019-09-30 | 2022-03-04 | 上海纽思克生物科技有限公司 | 四环嘧啶酮类化合物、其制备方法、其组合物和用途 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9421816D0 (en) | 1994-10-29 | 1994-12-14 | Smithkline Beecham Plc | Novel compounds |
| AP9701007A0 (en) | 1994-12-22 | 1997-07-31 | Smithkline Beecham Plc | Substituted azetidin-2-ones for treatment of atherosclerosis. |
| CH690264A5 (fr) | 1995-06-30 | 2000-06-30 | Symphar Sa | Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques. |
| PL324240A1 (en) | 1995-07-01 | 1998-05-11 | Smithkline Beecham Plc | Derivatives of azetidinone for treating atherosclerosis |
| CA2233300A1 (en) | 1995-09-29 | 1997-04-10 | Christopher Donald Southan | A paf-acetylhydrolase and use in therapy |
| WO1997021676A1 (en) | 1995-12-08 | 1997-06-19 | Smithkline Beecham Plc | Azetidinone compounds for the treatment of atherosclerosis |
| EP0869943A1 (en) | 1995-12-08 | 1998-10-14 | Smithkline Beecham Plc | Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| GB9608649D0 (en) | 1996-04-26 | 1996-07-03 | Smithkline Beecham Plc | Novel compounds |
| CZ341098A3 (cs) | 1996-04-26 | 1999-03-17 | Smithkline Beecham Plc | Azetidinonové deriváty pro ošetřování aterosklerózy |
| GB9626616D0 (en) | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
| GB9626615D0 (en) | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
| GB9626536D0 (en) | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
| JP2001522844A (ja) | 1997-11-06 | 2001-11-20 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ピリミジノン化合物およびそれを含有する医薬組成物 |
| JP2002523402A (ja) | 1998-08-21 | 2002-07-30 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | アテローム性動脈硬化症の治療用ピリミジノン |
| GB9910079D0 (en) | 1999-05-01 | 1999-06-30 | Smithkline Beecham Plc | Novel compounds |
| ES2233361T3 (es) | 1999-05-01 | 2005-06-16 | Smithkline Beecham Plc | Compuestos de piridinona. |
| GB9910378D0 (en) | 1999-05-05 | 1999-06-30 | Smithkline Beecham Plc | Novel compounds |
| JP3757703B2 (ja) | 1999-09-22 | 2006-03-22 | 凸版印刷株式会社 | 再封可能な開口維持部材付パウチ |
| SI1686119T1 (sl) | 2000-02-16 | 2009-12-31 | Smithkline Beecham Plc | Derivati pirimidin-5-ona kot inhibitorji ldl-pla2 |
| GB0024808D0 (en) | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
| GB0024807D0 (en) | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
| GB0119793D0 (en) | 2001-08-14 | 2001-10-03 | Smithkline Beecham Plc | Novel compounds |
| GB0119795D0 (en) | 2001-08-14 | 2001-10-03 | Smithkline Beecham Plc | Novel process |
| GB0127141D0 (en) | 2001-11-10 | 2002-01-02 | Smithkline Beecham Plc | Novel compounds |
| GB0127139D0 (en) | 2001-11-10 | 2002-01-02 | Smithkline Beecham | Novel compounds |
| GB0127140D0 (en) | 2001-11-10 | 2002-01-02 | Smithkline Beecham | Novel compounds |
| GB0127143D0 (en) | 2001-11-10 | 2002-01-02 | Smithkline Beecham | Novel compounds |
| GB0208280D0 (en) * | 2002-04-10 | 2002-05-22 | Glaxo Group Ltd | Novel compounds |
| GB0208279D0 (en) * | 2002-04-10 | 2002-05-22 | Glaxo Group Ltd | Novel compounds |
| EP1644353A1 (de) | 2003-07-02 | 2006-04-12 | Bayer HealthCare AG | Amid-substituierte 1, 2, 4-triazin-5 (2h) - one zur behandlung von chronisch inflammatorischen krankheiten |
| DE102004061008A1 (de) | 2004-12-18 | 2006-06-22 | Bayer Healthcare Ag | 3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one |
| DE102004061009A1 (de) | 2004-12-18 | 2006-06-22 | Bayer Healthcare Ag | Substituierte 1,2,4-Triazin-5(2H)-one |
| EP2083625A4 (en) * | 2006-10-13 | 2011-10-19 | Glaxo Group Ltd | BICYCLIC HETOROAROMATIC COMPOUNDS |
| US7705005B2 (en) | 2006-10-13 | 2010-04-27 | Glaxo Group Limited | Bicyclic heteroaromatic compounds |
| US20080090851A1 (en) | 2006-10-13 | 2008-04-17 | Colin Andrew Leach | Bicyclic Heteroaromatic Compounds |
| US20080090852A1 (en) | 2006-10-13 | 2008-04-17 | Colin Andrew Leach | Bicyclic Heteroaromatic Compounds |
| CN105748480A (zh) | 2007-05-11 | 2016-07-13 | 宾夕法尼亚大学理事会 | 治疗皮肤溃疡的方法 |
| US20080279846A1 (en) | 2007-05-11 | 2008-11-13 | Thomas Jefferson University | Methods of treatment and prevention of neurodegenerative diseases and disorders |
| US8962633B2 (en) | 2007-05-11 | 2015-02-24 | Thomas Jefferson University | Methods of treatment and prevention of metabolic bone diseases and disorders |
| JP2011088847A (ja) * | 2009-10-21 | 2011-05-06 | Takeda Chem Ind Ltd | 三環性化合物およびその用途 |
| EP2619203A4 (en) * | 2010-09-20 | 2014-04-16 | Glaxo Group Ltd | TRICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF |
| US8859573B2 (en) * | 2010-12-06 | 2014-10-14 | Glaxo Group Limited | Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 |
| EP2651403B1 (en) | 2010-12-17 | 2020-12-02 | Glaxo Group Limited | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases |
| AR087309A1 (es) * | 2011-07-27 | 2014-03-12 | Glaxo Group Ltd | Compuesto heterociclico de anillos condensados sustituido, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento para el tratamiento de enfermedades neurogenerativas y aterosclerosis |
-
2014
- 2014-01-23 WO PCT/CN2014/071206 patent/WO2014114249A1/en not_active Ceased
- 2014-01-23 AU AU2014210260A patent/AU2014210260B2/en not_active Ceased
- 2014-01-23 US US14/761,631 patent/US20150344485A1/en not_active Abandoned
- 2014-01-23 CA CA2899143A patent/CA2899143A1/en not_active Abandoned
- 2014-01-23 BR BR112015017397A patent/BR112015017397A2/pt not_active IP Right Cessation
- 2014-01-23 RU RU2015135824A patent/RU2015135824A/ru not_active Application Discontinuation
- 2014-01-23 EP EP14743086.2A patent/EP2948456A4/en not_active Withdrawn
- 2014-01-23 JP JP2015554039A patent/JP2016505053A/ja active Pending
- 2014-01-23 KR KR1020157022394A patent/KR20150108896A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150108896A (ko) | 2015-09-30 |
| CA2899143A1 (en) | 2014-07-31 |
| JP2016505053A (ja) | 2016-02-18 |
| WO2014114249A1 (en) | 2014-07-31 |
| RU2015135824A (ru) | 2017-03-03 |
| EP2948456A4 (en) | 2016-09-14 |
| US20150344485A1 (en) | 2015-12-03 |
| AU2014210260B2 (en) | 2016-08-04 |
| AU2014210260A1 (en) | 2015-07-30 |
| EP2948456A1 (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014001634A2 (pt) | compostos bicíclicos de pirimidona | |
| BR112015017397A2 (pt) | compostos pirimidona bicíclica como inibidores de lp-pla2 | |
| BR112012020693A2 (pt) | derivados de ciclobutano e metilciclobutano como inibidores de janus quinase | |
| BR112015010663A8 (pt) | formas de dosagem oral de liberação sustentada, e uso de ruxolitinib ou de sal farmaceuticamente aceitável do mesmo | |
| BR112014001665A2 (pt) | compostos de 2,3-di-hidroimidazo[1,2-c]pirimidin-5(1h)-ona utilizados como inibidores de lp-plaz | |
| EA201990665A1 (ru) | Регуляторы hpk1 на основе производных пиразолопиридина и их применение для лечения рака | |
| BR112015028501A2 (pt) | derivados de bipirazol como inibidores de jak | |
| DOP2016000195A (es) | Compuestos | |
| BR112015021888A8 (pt) | inibidores de dna-pk, seus usos e composição farmacêutica | |
| CO2017011851A2 (es) | Compuestos novedosos | |
| BR112017005531A2 (pt) | derivados de diaril ureia como inibidores de quinase p38 | |
| CO7170166A2 (es) | Inhibidores de pi3k delta selectivos | |
| PH12016500531B1 (en) | Compound inhibiting activities of btk and/or jak3 kinases | |
| PH12015501586A1 (en) | 2,3-dihydroimidazol[1,2-c]pyrimidin-5(1h)-one based lipoprotein-associated phospholipase a2 (lp-pla2) inhibitors | |
| BR112014026952A8 (pt) | derivados de aminopirimidina pirazol, seus usos, e composição | |
| MX381260B (es) | Inhibidores heterociclicos de glutaminasa. | |
| UY33766A (es) | COMPUESTOS CON ESTRUCTURA DE PIRIMIDINONA PARA USO EN EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR Lp-PLA2 | |
| BR112014026703A2 (pt) | inibidores de dna-pk | |
| CU20130115A7 (es) | Compuestos y composiciones como inhibidores de trk | |
| BR112015015635A2 (pt) | inibidores de quinases de proteínas | |
| BR112015024671A2 (pt) | derivados de ureia úteis como inibidores de quinase | |
| BR112012022650A8 (pt) | derivados de imidazo [1,2-a]pirazina e seu uso como inibidores de pde10 | |
| BR112018008431A2 (pt) | composto de [1,2,4]triazolo[1,5-a]pirimidin-7-il | |
| UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
| BR112013019354A2 (pt) | derivados de (1,2,4)triazolo[4,3-a]quinoxalina como inibidores de fosfodiesterases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2498 DE 21-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |